Showing 1 - 3 results of 3 for search 'William L Redmond', query time: 0.01s Refine Results
  1. 1
    Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy

    Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy by Kengo Tanigawa, William L. Redmond

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8+ T cell responses capable of curing multi-focal cancer

    NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8+ T cell responses capable of curing multi-focal cancer by William L Redmond, Ute Hoch, Melissa J Kasiewicz, Michael J McNamara, Deborah H Charych, Joshua M Walker, Annah S Rolig, Daniel C Rose, Ian F Hilgart-Martiszus

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

    A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone by Yiyi Chen, Charles G Drake, William L Redmond, Yoshinobu Koguchi, Tomasz M Beer, Julie N Graff, Joshi J Alumkal, Rachel E Slottke, George V Thomas, Reid F Thompson, Mary A Wood, Emile Latour, Raymond C Bergan, Amy E Moran

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: